RxDoctor Payments Data

Obed Anya

Psychiatric/Mental Health · Cincinnati, OHNPI 1245529957

Payments from drug & device makers

$1,261in general payments, 2019–2025

Across 80 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$410
  • AbbVie$364
  • Vanda Pharmaceuticals Inc.$225
  • Axsome Therapeutics, Inc.$103
  • Teva Pharmaceuticals USA, Inc.$86
  • Almatica Pharma LLC$34
  • plus $39 from 2 others

What the payments were for

  • Food & beverage$1,261100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,261 in reported general payments places this provider in the 65th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$13,032
Medicare patients
14
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine15$95,738
VraylarCariprazine Hcl53$77,958
RexultiBrexpiprazole15$21,614
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl118$19,037
Paliperidone ErPaliperidone15$6,270
Aripiprazole50$4,346
Buprenorphine Hcl58$1,853
Quetiapine Fumarate71$1,469
Divalproex Sodium ErDivalproex Sodium23$886
Hydroxyzine Pamoate70$869
Ziprasidone Hcl13$653
Fluoxetine Hcl93$631
Atomoxetine Hcl14$506
Olanzapine21$470
Naloxone Hcl15$467

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$86$95,73815 claims
AbbVieVraylar$364$77,95853 claims
Otsuka America Pharmaceutical, Inc.Rexulti$410$21,61415 claims
Almatica Pharma LLCSertraline Hcl$34$6817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →